Power Minerals partners with Summit for Salta Lithium
Power Minerals (ASX:PNN) has executed a non-binding term sheet with Summit Explore, a subsidiary of Summit Nanotech.
Power Minerals (ASX:PNN) has executed a non-binding term sheet with Summit Explore, a subsidiary of Summit Nanotech.
Dino Otranto, CEO at Fortescue Metals, discusses the impact of the Iran war on the business and energy markets. He speaks with Stephen Engle at the China Development Forum in Beijing.
South Korean AI startup Upstage says it's in talks with its investor, AMD, for the potential purchase of 10,000 AI chips. Upstage CEO Sung Kim discusses his recent meeting with AMD chief Lisa Su in Seoul, as well as his company's edge in competing in South Korea's AI 'squid game'. He speaks with Minmin Low at the Milken Institute's "Global Investors' Symposium" in Hong Kong.
The Laundy Family announced that Nine Radio will be rebranded as Tapt Media once the acquisition of the audio business is finalised.
Perry Wong, Senior Fellow at the Milken Institute, discusses the outlook for China's economy and the impact from the war in Iran. He speaks with Minmin Low from the sidelines of the Milken Institute's Global Investors' Symposium in Hong Kong.
Boom Logistics (ASX:BOL) appointed Pieter Le Roux as its new permanent CFO, effective March 24.
European Union President Ursula von der Leyen arrived in Sydney on March 23 for a high-stakes three-day visit.
Energy Technologies (ASX:EGY) announced the acquisition of Maradin’s Laser Optical Engineering Intellectual Property portfolio.
Desert Minerals (ASX:DSM) commenced its highly anticipated 2026 drilling program at the Scotty Lithium Project.
UBS Group CEO Sergio Ermotti says the firm's customers aren't making dramatic changes to asset allocation as a result of the Middle East conflict, but digesting the full impact of the war will take time. Ermotti speaks with Bloomberg's Stephen Engle in Beijing.
Felix Gold (ASX:FXG) marked a milestone following the receipt of a bulk sampling permit from the Alaska Department of Natural Resources.
Melbourne-based Amplia Therapeutics (ASX:ATX) announced a clinical breakthrough in the treatment of advanced pancreatic cancer.